SUPERNUS PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
  • Supernus Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $135M, a 7.48% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $621M, a 25.8% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $494M, a 42.4% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $347M, a 42% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $621M +$127M +25.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $494M +$147M +42.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $347M +$103M +42% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $244M -$20.3M -7.66% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $264M +$61.8M +30.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $203M +$41.9M +26.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $161M +$34.2M +27% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $127M +$28.7M +29.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $98M +$24M +32.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $73.9M +$30.3M +69.4% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $43.6M +$5.09M +13.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $38.6M -$1.67M -4.16% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 $40.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.